Le Dr Alemdar se spécialise dans les tumeurs surrénaliennes, avec une formation à l'hôpital universitaire d'Akdeniz – un centre de premier plan pour les soins oncologiques.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
L'Assoc. Prof. Nail Paksoy combine plus de 11 ans d'expérience spécialisée en oncologie avec une participation active à 8 essais internationaux sur le cancer à l'hôpital Medipol Bahçelievler.
Formé en chirurgie laparoscopique avancée à l'Université d'Istanbul – spécialisé dans les procédures mini-invasives pour les tumeurs surrénaliennes.
Le Dr Volkan Kinas est spécialisé en chirurgie oncologique, avec un accent particulier sur les cas de tumeurs complexes aux hôpitaux Büyük Anadolu.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Spécialisation en radio-oncologie à l'Université de Marmara – formation ciblée sur les traitements avancés des tumeurs surrénaliennes.
Avec plus de 40 ans d'expérience en ORL et en chirurgie de la tête et du cou, le Dr Ozdemir apporte une expertise approfondie aux cas de tumeurs surrénaliennes.
Le professeur associé Dr Emrah Eraslan est spécialisé dans les tumeurs surrénaliennes, avec une formation approfondie en oncologie médicale à l'hôpital de recherche et de formation en oncologie Dr Abdurrahman Yurtaslan d'Ankara.
Spécialisé en oncologie urologique et en procédures laparoscopiques – le Dr Akman apporte de la précision aux traitements des tumeurs surrénaliennes à l'hôpital Medicana Bahcelievler.
Le professeur Ahmet Cag Cal apporte des décennies d'expérience spécialisée en urologie, incluant une formation au Memorial Sloan-Kettering Cancer Center et à l'UCLA.
Le Prof. Engin apporte des décennies d'expertise en radio-oncologie, y compris un fellowship prestigieux à l'Université Thomas Jefferson aux États-Unis.